Type 1 diabetes

Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemic

Diabetes Res Clin PractPublished Registry-based survey study

Authors' conclusion

Changes to models of care delivery driven by the pandemic showed significant associations with HbA1c shortly after the pandemic outbreak and 2 years of follow-up. The association appeared independent of the concomitant increase in technology use among youth with type 1 diabetes.

Study context

Population
Youth with T1D (duration >3 months, aged ≤21 years) in SWEET registry centers, 2018–2021
Participants
42,798 participants70 centers
Exposure
Changes to models of care delivery during COVID-19
Outcome
HbA1c trend 2018–2021 by care model
Follow-up
2018 to 2021
Methodological detailsonline questionnaire, international registry (SWEET), Questionnaire sent to 97 centers (66,985 youth with T1D); 82 responded
  • Online questionnaire
  • International registry (SWEET)
  • Questionnaire sent to 97 centers (66,985 youth with T1D); 82 responded

Main finding

As reported in the abstract

Partial telemedicine centers: steady increase in HbA1c between 2018 and 2021
p < 0.001
Mainly telemedicine centers: improved HbA1c in 2021 vs 2018
p < 0.001

Observational data: associations, not effects.

Further findings

Telemedicine provision during COVID-19

Centers providing telemedicine during COVID-19
65
Telemedicine-naive centers before pandemic
22
Of telemedicine-naive centers, continued only face-to-face visits
4

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemic. Diabetes Res Clin Pract. Published 27 June 2023. doi:10.1016/j.diabres.2023.110809

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.